Logo image of ALX.AS

ALUMEXX N.V. (ALX.AS) Stock Fundamental Analysis

AMS:ALX - Euronext Amsterdam - NL0012194724 - Common Stock - Currency: EUR

1.29  +0.01 (+0.78%)

Fundamental Rating

2

Taking everything into account, ALX scores 2 out of 10 in our fundamental rating. ALX was compared to 22 industry peers in the Building Products industry. ALX has a bad profitability rating. Also its financial health evaluation is rather negative. ALX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ALX had negative earnings in the past year.
In the past year ALX had a positive cash flow from operations.
Of the past 5 years ALX 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: ALX reported negative operating cash flow in multiple years.
ALX.AS Yearly Net Income VS EBIT VS OCF VS FCFALX.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 500K -500K 1M 1.5M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.22%, ALX is doing worse than 81.82% of the companies in the same industry.
ALX's Return On Equity of -18.83% is on the low side compared to the rest of the industry. ALX is outperformed by 86.36% of its industry peers.
ALX has a Return On Invested Capital of 2.86%. This is in the lower half of the industry: ALX underperforms 68.18% of its industry peers.
ALX had an Average Return On Invested Capital over the past 3 years of 11.11%. This is above the industry average of 8.76%.
The last Return On Invested Capital (2.86%) for ALX is well below the 3 year average (11.11%), which needs to be investigated, but indicates that ALX had better years and this may not be a problem.
Industry RankSector Rank
ROA -2.22%
ROE -18.83%
ROIC 2.86%
ROA(3y)5.99%
ROA(5y)6.16%
ROE(3y)10.32%
ROE(5y)11.5%
ROIC(3y)11.11%
ROIC(5y)11.66%
ALX.AS Yearly ROA, ROE, ROICALX.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60

1.3 Margins

ALX has a worse Operating Margin (2.84%) than 81.82% of its industry peers.
In the last couple of years the Operating Margin of ALX has declined.
ALX has a Gross Margin of 47.69%. This is in the better half of the industry: ALX outperforms 63.64% of its industry peers.
In the last couple of years the Gross Margin of ALX has grown nicely.
Industry RankSector Rank
OM 2.84%
PM (TTM) N/A
GM 47.69%
OM growth 3Y-4.18%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y26.33%
GM growth 5Y15.87%
ALX.AS Yearly Profit, Operating, Gross MarginsALX.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K -8K -10K

More info and screens

2

2. Health

2.1 Basic Checks

ALX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for ALX has been increased compared to 1 year ago.
Compared to 5 years ago, ALX has more shares outstanding
ALX has a worse debt/assets ratio than last year.
ALX.AS Yearly Shares OutstandingALX.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M
ALX.AS Yearly Total Debt VS Total AssetsALX.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of 0.89, we must say that ALX is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ALX (0.89) is worse than 90.91% of its industry peers.
ALX has a debt to FCF ratio of 5.90. This is a neutral value as ALX would need 5.90 years to pay back of all of its debts.
ALX has a Debt to FCF ratio (5.90) which is comparable to the rest of the industry.
ALX has a Debt/Equity ratio of 4.77. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of ALX (4.77) is worse than 90.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.77
Debt/FCF 5.9
Altman-Z 0.89
ROIC/WACC0.36
WACC7.95%
ALX.AS Yearly LT Debt VS Equity VS FCFALX.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M 20M

2.3 Liquidity

A Current Ratio of 1.81 indicates that ALX should not have too much problems paying its short term obligations.
ALX has a better Current ratio (1.81) than 72.73% of its industry peers.
A Quick Ratio of 0.56 indicates that ALX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.56, ALX is doing worse than 86.36% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 0.56
ALX.AS Yearly Current Assets VS Current LiabilitesALX.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

3

3. Growth

3.1 Past

ALX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -270.45%.
ALX shows a strong growth in Revenue. In the last year, the Revenue has grown by 105.19%.
Measured over the past years, ALX shows a very strong growth in Revenue. The Revenue has been growing by 85.44% on average per year.
EPS 1Y (TTM)-270.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%261.87%
Revenue 1Y (TTM)105.19%
Revenue growth 3Y102.7%
Revenue growth 5Y85.44%
Sales Q2Q%37.86%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALX.AS Yearly Revenue VS EstimatesALX.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ALX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALX.AS Price Earnings VS Forward Price EarningsALX.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

63.64% of the companies in the same industry are more expensive than ALX, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALX indicates a rather cheap valuation: ALX is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.06
EV/EBITDA 6.76
ALX.AS Per share dataALX.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALUMEXX N.V.

AMS:ALX (6/2/2025, 7:00:00 PM)

1.29

+0.01 (+0.78%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners53.39%
Ins Owner ChangeN/A
Market Cap9.03M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.22
P/FCF 2.06
P/OCF 1.74
P/B 1.98
P/tB N/A
EV/EBITDA 6.76
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.63
FCFY48.62%
OCF(TTM)0.74
OCFY57.6%
SpS5.74
BVpS0.65
TBVpS-1.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.22%
ROE -18.83%
ROCE 3.81%
ROIC 2.86%
ROICexc 3%
ROICexgc 6.47%
OM 2.84%
PM (TTM) N/A
GM 47.69%
FCFM 10.94%
ROA(3y)5.99%
ROA(5y)6.16%
ROE(3y)10.32%
ROE(5y)11.5%
ROIC(3y)11.11%
ROIC(5y)11.66%
ROICexc(3y)14.91%
ROICexc(5y)27.71%
ROICexgc(3y)26.54%
ROICexgc(5y)N/A
ROCE(3y)14.88%
ROCE(5y)15.59%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-62.74%
ROICexc growth 5YN/A
OM growth 3Y-4.18%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y26.33%
GM growth 5Y15.87%
F-Score6
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 4.77
Debt/FCF 5.9
Debt/EBITDA 4.4
Cap/Depr 21.27%
Cap/Sales 2.02%
Interest Coverage 0.78
Cash Conversion 105.03%
Profit Quality N/A
Current Ratio 1.81
Quick Ratio 0.56
Altman-Z 0.89
F-Score6
WACC7.95%
ROIC/WACC0.36
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-270.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%261.87%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)105.19%
Revenue growth 3Y102.7%
Revenue growth 5Y85.44%
Sales Q2Q%37.86%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y256.25%
EBIT growth 3Y94.22%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y928.3%
FCF growth 3Y-27.63%
FCF growth 5Y-2.56%
OCF growth 1Y1081.32%
OCF growth 3Y16.38%
OCF growth 5Y29.58%